Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Erratum (v15,pA7)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Afzali, B.
Right arrow Articles by Goldsmith, D. J.A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Afzali, B.
Right arrow Articles by Goldsmith, D. J.A.
J Am Soc Nephrol 15:2161-2168, 2004
© 2004 American Society of Nephrology

CLINICAL SCIENCE

From Finland to Fatland: Beneficial Effects of Statins for Patients with Chronic Kidney Disease

Behdad Afzali, Ali A. Haydar, Katie Vinen and David J.A. Goldsmith

Renal Medicine and Transplantation, Guy’s Hospital, London, United Kingdom

Correspondence to Dr. David Goldsmith, Consultant Nephrologist, Renal Medicine and Transplantation, Guy’s Hospital, London SE1 9RT, UK. Phone: 0044-2071887188; Fax: 0044-2071885646; E-mail: David.goldsmith{at}gstt.sthames.nhs.uk




This article has been cited by other articles:


Home page
 Diabetes CareHome page
Z. T. Bloomgarden
Diabetic Nephropathy
Diabetes Care, April 1, 2008; 31(4): 823 - 827.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
V. Kolavennu, L. Zeng, H. Peng, Y. Wang, and F. R. Danesh
Targeting of RhoA/ROCK Signaling Ameliorates Progression of Diabetic Nephropathy Independent of Glucose Control
Diabetes, March 1, 2008; 57(3): 714 - 723.
[Abstract] [Full Text] [PDF]

Home page
 CJASNHome page
J. Nogueira and M. Weir
The Unique Character of Cardiovascular Disease in Chronic Kidney Disease and Its Implications for Treatment with Lipid-Lowering Drugs
Clin. J. Am. Soc. Nephrol., July 1, 2007; 2(4): 766 - 785.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
M. Tonelli
Do statins protect the kidney as well as the heart?
Nephrol. Dial. Transplant., November 1, 2006; 21(11): 3005 - 3006.
[Full Text] [PDF]

Home page
 ANN INTERN MEDHome page
M. Tonelli
Do Statins Protect the Kidney by Reducing Proteinuria?
Ann Intern Med, July 18, 2006; 145(2): 147 - 149.
[Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
G. Tsirpanlis, F. Boufidou, F. Alevyzaki, and E. Psimenou
Statins and progression of renal failure: is a reconsideration of clinical practice guidelines justified?
Nephrol. Dial. Transplant., May 1, 2005; 20(5): 1015 - 1016.
[Full Text] [PDF]


HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP

Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673